{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:50:10Z","timestamp":1793379010528,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"H\u00e4me Students Foundation sr, Helsinki, Finland"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.drugalcdep.2020.108345","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:44:12Z","timestamp":1603536252000},"page":"108345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Concomitant drugs with buprenorphine user deaths"],"prefix":"10.1016","volume":"218","author":[{"given":"Claudia","family":"Mariottini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkko","family":"Kriikku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108345_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment \u2013 A nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008-2013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0025","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1360-0443.2009.02570.x","article-title":"Mortality among opiate users: opioid maintenance therapy, age and causes of death","volume":"104","author":"Clausen","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.301.1.266","article-title":"Intravenous buprenorphine self-administration by detoxified heroin abusers","volume":"301","author":"Comer","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0035","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-018-0953-z","article-title":"Treating chronic pain: an overview of clinical studies centered on the buprenorphine option","volume":"78","author":"Davis","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0045","series-title":"Finland Country Drug Report 2019","author":"EMCDDA: European Monitoring Centre for Drugs and Drug Addiction","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0050","series-title":"Drugs in Syringes From Six European Cities: Results From the ESCAPE Project 2017, Publications Office of the European Union, Luxembourg","author":"EMCDDA: European Monitoring Centre for Drugs and Drug Addiction","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of Pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0060","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.forsciint.2010.05.015","article-title":"Fatal poisoning due to snorting buprenorphine and alcohol consumption","volume":"204","author":"Ferrant","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0065","series-title":"Finnish Customs: Finnish Customs Enforcement","author":"Finnish Customs: Finnish Customs Enforcement","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0070","article-title":"Methadone-related deaths among youth and young adults in Sweden 2006-15","author":"Fugelstad","year":"2020","journal-title":"Addiction."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09595230701373834","article-title":"Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records","volume":"26","author":"Gibson","year":"2007","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","article-title":"Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","volume":"68","author":"H\u00e4kkinen","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.forsciint.2013.06.017","article-title":"Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning","volume":"232","author":"H\u00e4kkinen","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/add.14014","article-title":"Non-medical use of psychoactive prescription drugs is associated with fatal poisoning","volume":"113","author":"Haukka","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12888-017-1415-y","article-title":"Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine","volume":"17","author":"Heikman","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000377628","article-title":"Has previous abuse of flunitrazepam been replaced by clonazepam?","volume":"21","author":"H\u00f8iseth","year":"2015","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0115","first-page":"34","article-title":"Health risks of drugs in Finland - can the risks be managed?","volume":"133","author":"Kauhanen","year":"2017","journal-title":"Duodecim"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugpo.2017.05.039","article-title":"Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone","volume":"46","author":"Kelty","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00952990.2019.1698587","article-title":"A comparison of blood toxicology in fatalities involving alcohol and other drugs in patients with an opioid use disorder treated with methadone, buprenorphine, and implant naltrexone","volume":"46","author":"Kelty","year":"2020","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.forsciint.2018.08.010","article-title":"High buprenorphine-related mortality is persistent in Finland","volume":"291","author":"Kriikku","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drugalcdep.2016.03.017","article-title":"Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients","volume":"162","author":"Launonen","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/PRA.0000000000000154","article-title":"Buprenorphine prescribing: to expand or not to expand","volume":"22","author":"Li","year":"2016","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002965","article-title":"Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records","volume":"16","author":"Macleod","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007629","article-title":"The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales","volume":"5","author":"Marteau","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","article-title":"Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences","volume":"25","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0165","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/add.14886","article-title":"Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine","volume":"115","author":"Park","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0170","first-page":"927","article-title":"The prevalence of high-risk amphetamine and opioid use in Finland in 2017","volume":"136","author":"R\u00f6nk\u00e4","year":"2020","journal-title":"Duodecim"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.forsciint.2012.03.016","article-title":"Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome","volume":"220","author":"Seld\u00e9n","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"110343","key":"10.1016\/j.drugalcdep.2020.108345_bib0180","article-title":"Fatal poisoning in drug addicts in the Nordic countries in 2017","volume":"313","author":"Simonsen","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0185","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","volume":"68","author":"Stein","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0195","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jat\/22.6.430","article-title":"Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities","volume":"22","author":"Tracqui","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2012.07.002","article-title":"Twelve-year trend in treatment seeking for buprenorphine abuse in Finland","volume":"127","author":"Uosukainen","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.drugalcdep.2013.06.022","article-title":"Mortality among clients seeking treatment for buprenorphine abuse in Finland","volume":"133","author":"Uosukainen","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jsat.2014.01.004","article-title":"Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland","volume":"46","author":"Uosukainen","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans: partial agonist and blockade effects","volume":"274","author":"Walsh","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0220","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/add.12971","article-title":"Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England","volume":"110","author":"White","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0225","article-title":"Opioid overdose deaths with buprenorphine detected in postmortem toxicology: a retrospective analysis","author":"Wightman","year":"2020","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0230","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/dar.12143","article-title":"Opioid-related mortality and filled prescriptions for buprenorphine and methadone","volume":"33","author":"Wikner","year":"2014","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.clpt.6100025","article-title":"Mechanism-based PK\/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers","volume":"81","author":"Yassen","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.drugalcdep.2020.108345_bib0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.drugalcdep.2018.02.019","article-title":"Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: using the prescription behavior surveillance system","volume":"187","author":"Zhu","year":"2018","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162030510X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162030510X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:12:29Z","timestamp":1759828349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687162030510X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":49,"alternative-id":["S037687162030510X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108345","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant drugs with buprenorphine user deaths","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108345"}}